GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Operational & Financial Ratios | |||
| Earnings Per Share (Rs) | 6.40 | 6.95 | 8.59 |
| CEPS(Rs) | 9.48 | 9.05 | 10.29 |
| DPS(Rs) | 0.10 | 0.10 | 0.10 |
| Book NAV/Share(Rs) | 66.31 | 59.93 | 53.11 |
| Tax Rate(%) | 25.81 | 26.02 | 25.53 |
| Margin Ratios | |||
| Core EBITDA Margin(%) | 12.38 | 12.37 | 15.67 |
| EBIT Margin(%) | 10.08 | 10.78 | 14.09 |
| Pre Tax Margin(%) | 7.08 | 8.56 | 12.30 |
| PAT Margin (%) | 5.25 | 6.33 | 9.16 |
| Cash Profit Margin (%) | 7.78 | 8.24 | 10.97 |
| Performance Ratios | |||
| ROA(%) | 5.11 | 6.16 | 7.88 |
| ROE(%) | 10.14 | 12.29 | 16.17 |
| ROCE(%) | 12.56 | 13.48 | 15.59 |
| Asset Turnover(x) | 0.97 | 0.97 | 0.86 |
| Sales/Fixed Asset(x) | 1.96 | 2.56 | 3.82 |
| Working Capital/Sales(x) | 4.30 | 4.64 | 4.12 |
| Efficiency Ratios | |||
| Fixed Capital/Sales(x) | 0.51 | 0.39 | 0.26 |
| Receivable days | 91.39 | 106.89 | 128.09 |
| Inventory Days | 80.84 | 69.22 | 77.83 |
| Payable days | 187.06 | 191.37 | 178.99 |
| Valuation Parameters | |||
| PER(x) | 42.88 | 48.44 | 32.96 |
| PCE(x) | 28.97 | 37.19 | 27.53 |
| Price/Book(x) | 4.14 | 5.61 | 5.33 |
| Yield(%) | 0.04 | 0.03 | 0.04 |
| EV/Net Sales(x) | 3.24 | 4.46 | 3.90 |
| EV/Core EBITDA(x) | 19.89 | 26.16 | 21.03 |
| EV/EBIT(x) | 24.86 | 30.80 | 23.73 |
| EV/CE(x) | 2.92 | 4.01 | 3.70 |
| M Cap / Sales | 2.92 | 4.12 | 3.52 |
| Growth Ratio | |||
| Net Sales Growth(%) | 15.15 | 1.63 | - |
| Core EBITDA Growth(%) | 10.21 | -6.52 | - |
| EBIT Growth(%) | 3.79 | -10.42 | - |
| PAT Growth(%) | -7.81 | -19.14 | - |
| EPS Growth(%) | -7.81 | -19.14 | - |
| Financial Stability Ratios | |||
| Total Debt/Equity(x) | 0.58 | 0.52 | 0.60 |
| Current Ratio(x) | 1.55 | 1.61 | 1.61 |
| Quick Ratio(x) | 0.92 | 1.05 | 1.08 |
| Interest Cover(x) | 3.36 | 4.84 | 7.89 |
| Total Debt/Mcap(x) | 0.14 | 0.09 | 0.11 |
Compare Financial Ratios of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,122.3 Cr | -5.1% | 7.6% | 9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -5.1% |
7.6% |
9.7% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses
